Impact of vaccination with seven-valent pneumococcal conjugate vaccine on virologic and immunologic outcomes among HIV-infected adult patients in the era of highly active antiretroviral therapy

Impact of vaccination with seven-valent pneumococcal conjugate vaccine on virologic and immunologic outcomes among HIV-infected adult patients in the era of highly active antiretroviral therapy

Pneumococcal polysaccharide vaccination may be associated with adverse outcomes in HIV-infected individuals who did not receive highly active antiretroviral therapy (HAART). Our aim was to evaluate the impact of vaccination with seven-valent pneumococcal conjugate vaccine (PCV) on the short-term cli...

Full description

Bibliographic Details
Main Authors: Ching-Lan Lu, Sui-Yuan Chang, Hsin-Yun Sun, Wen-Chun Liu, Yu-Tzu Tseng, Chia-Ying Hsieh, Cheng-Hsin Wu, Chien-Ching Hung, Shan-Chwen Chang
Format: Article
Language:English
Published: Elsevier 2012-08-01
Series:Journal of the Formosan Medical Association
Subjects:
antiretroviral therapy
highly active antiretroviral therapy
HIV infection
HIV RNA load
pneumococcal conjugate vaccine
Streptococcus pneumoniae
Online Access:http://www.sciencedirect.com/science/article/pii/S0929664612000794

Internet

http://www.sciencedirect.com/science/article/pii/S0929664612000794

Similar Items